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Summary
Tumor necrosis factor a (TNF-a), in addition to being cytotoxic for certain tumor cells, has
turned out as a multifunctional cytokine that is involved in the regulation of immunity and
inflammation. Sincehuman keratinocytes have beendemonstrated tobe apotent source ofvarious
cytokines, itwas investigated whether epidermal cellssynthesize andreleaseTNF-m Supernatants
derived from normal human keratinocytes (HNK) and human epidermoid carcinoma cell lines
(KB, A431) were tested bothinaTNF-a-specific ELISAand abioassay. Insupernatants ofuntreated
epidermal cells, no or minimal TNF-a activity was found, while after stimulation with
lipopolysaccharide (LPS) or ultraviolet (UV) light, significant amounts were detected. Western
blot analysis using an antibody directed against human TNF-a revealed a molecular mass of
17kDfor keratinocyte-derived TNF-a. Thesebiological and biochemical data werealsoconfirmed
by Northern blot analysis revealing mRNAspecific for TNF-a in LPS- or ultraviolet B (UVB)-
treatedHNK and KBcells. Inaddition, increased TNF-alevelsweredetected in theserumobtained
from human volunteers 12 and 24 h after a single total body UVB exposure, which caused a
severe sunburn reaction. These findings indicate that keratinocytes upon stimulation are able
to synthesize and release TNF-a, which may gain access to the circulation. Thus, TNF-a in
concert withother epidermalcell-derived cytokinesmaymediate localand systemic inflammatory
reactionsduring host defenseagainstinjuriousevents caused bymicrobial agents orUVirradiation.
T
NF-a/cachectin hasbeen originally describedas a macro-
phage-derived factor that induces cachexia and hemor-
rhagic necrosis oftumors inanimals, and ports cytolytic effects
on several tumorcelllines (1-3). In the meantime, it became
evident thatTNF-aexhibits avariety ofactivities, including
release ofprostaglandins and collagenase (4), and activation
ofneutrophils(5), eosinophils, andmacrophages (6).Moreover,
TNF-a increases MHC class I antigen (7) and intercellular
adhesion molecule (ICAM)r expression on many cells (8),
and induces the release of other cytokines. Through these
multiple effects, TNF-a appears to be an essential mediator
in inflammatory and immunologic reactions during host
defense.
In addition to their barrier function, epidermal cells and,
in particular, keratinocytes have been recently recognized to
1 Abbreviations used in thispaper. GM-CSF, granulocyte/macrophage CSF;
HNK, normal human keratmocytes; ICAM, intercellular adhesion molecule,
LC, Langerhans cell; UVB, ultraviolet B.
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exhibit the capacity to release avariety ofsoluble mediators,
including 111, Hr6,IIr8, CSF, transforming growth factors,
and platelet-derived growth factor, that influencethegrowth,
differentiation, and function ofepidermal, dermal, and im-
munocompetent cells (9-11). Theconstitutive productionof
thesefactorsusuallyisverylowbutcanbeinducedsignificantly
by various injurious agents, such as endotoxin, viral parti-
cles, tumor promotors, or UV light (9, 11). Consequently,
thesecytokines arenotonlyinvolved in the mediationoflocal
inflammatory reactions within the epidermis, but may also
enter the circulation and thus cause systemic effects. There-
fore, thepresent studywasperformedtoinvestigate whether
human keratinocytes in addition to these mediators can also
release the multifunctional cytokine TNF-a/cachectin.
Materials and Methods
CellsandCellLines.
￿
Long-termcultures ofnormal humanker-
atinocytes (HNK) were obtained from normal human foreskin as
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Figure 1.
￿
Humanepidermoid carcinoma cell fine cells(KB) releaseTNF-a
upon stimulation with LPS (100 pg/ml). Supernatants of untreated or
LPS-treated KB cells were harvestedat different time points after stimula-
tion and tested for TNF-ca activity by the use of a TNF-a ELISA.
describedpreviously andmaintained in KGM(Clonetics, SanDiego,
CA) (12). Hydrocortisone was omitted from the culture medium
48 h before testing. The human epidermoid carcinoma cell lines
KB andA431 (AmericanType CultureCollection, Rockville, MD)
were maintained in monolayer cultures at 37°C in a humidified
atmosphere containing 5% C02. To investigate factor production,
cells were plated at a density of 5 x 105/ml in 24-well plates
(Costar, Cambridge, MA), and supernatants were harvested at
differenttime points (1, 3, 6, 12,24,or 48 h),centrifuged at 1,000g,
andstored at -20°C.To stimulatecytokine production, cellswere
irradiated with ultraviolet B (UVB) light (FS20 bulbs; 10-200
J/m2) according to an established protocol (13) or cultured in the
presence of LPS (100 Fig/ml; Difco Laboratories, Detroit, MI).
In Vivo Exposure.
￿
After informed consent was obtained, four
human volunteers were exposed to a single total body UVB ex-
posure equivalent to four minimal erythema doses as previously
described (14). As a light source, an unfiltered bank of six blue
light lamps (Dr. Hoelmle, Munich, FRG) was used, emitting a
linear spectrum between 250 and600 nm with emission peaks at
300and360nm,respectively. Bloodwas drawnfrom theantecub-
ital vein into sterile heparinized tubes immediately before UV ex-
posure, as well as 12 and 24 h after UV treatment.
Assayfor TNFa.
￿
TNF-acontent ofepidermalcell culture su-
pernatants was assayed by determining the cytotoxicity of TNF-a
against sensitive murine IrMcells (15). Briefly, IM cells were seeded
at aconcentrationof 4 x 10' cells/well in 100 Al culture medium
and incubated for 22-24 h at 37°C in a 5% CO2 atmosphere to
establish a dense monolayer. 0.1 ml of culture supernatants to be
tested was added in the presence of actinomycin D (2 pg/ml) for
18 h. Viability of cellswas measured by staining with 0.5% crystal
violet. Afterremoval ofexcess dyeanddrying, absorbance was de-
termined at 540 nm using a microplate reader (3550; Bio-Rad
Laboratories, Richmond, CA).
In addition, acommercially available ELISA was used for mea-
suring human TNF-a (Endogen, Boston, MA). This kit is based
on the use of a mouse anti-TNF-a mAb and a rabbit polyvalent
antiTNF-a antibody. It is sensitiveto 10 pg/mlTNF-a anddoes
not crossreact with human lymphotoxin (TNF-0), ID1, or IL6.
Western Blot Analysis.
￿
Supernatants to be tested were concen-
trated 100timesbyusingAmicon ultrafiltration andwere subjected
9o
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Figure 2.
￿
Epidermalcells release biologically active TNF-a. Superna-
tantsof HNK, KB,or A431 cellseither untreated or stimulated with LPS
(100 pg/ml) were tested in theTNF-a-specific IPMbioassay. Culture su-
pernatants were harvested 24 h after stimulation.
to SDS-PAGE (15% totalacrylamide concentration) underreducing
conditions (16).AfterSDS-PAGE,proteins were electrotransferred
to nitrocellulose and stained with a mouse mAb directed against
recombinant human TNF-a (kindly provided by G. Adolf, Ernst-
Boehringer Institute, Vienna, Austria). Biotinylated molecular
weight markerswere obtained from Sigma Chemical Co.(St. Louis,
MO).
Northern Blot Analysis.
￿
Cultured cells were detached by treat-
ment with ice-cold PBSandlysedin 4Mguanidineisothiocyanate.
RNAwasisolated by ultracentrifugation throughcesium chloride,
and subjected to electrophoresis in 1.0% agarose gel containing
formaldehyde (2.2 M). Aftercapillary transfer ofRNAto nitrocel-
lulose, membranes were prehybridized for at least 4 h with use
of hybridizing solution containing 10% dextrane sulfate, 40% for-
mamide, 20% 20x SSC, sonicatedsalmon spermDNA(50pg/ml),
and yeasttransfer RNA(50pg/ml). TNF-ac mRNA wasdetected
by hybridization with a 0.8-kb EcoRl cDNA fragment (kindly
provided by D.Pennica, Genentech, SanFrancisco, CA). Afterstrin-
gent washing conditions, blotswere exposed to x-rayfilm at -70°C
for 24 h (17).
When epidermalcell-derived supernatants were evaluated
for TNF-a production using a TNF-a-specific ELISA, no
or only minimal amounts were found in conditioned medium
obtained from unstimulated KB cells. However, when KB
cellswere treated with LPS (100 pg/ml), significant amounts
of TNFLoi were detected. TNF-arelease started 1 hafter stim-
ulationandpeaked at x+12 h, retuming to base line after 48 h
(Fig. 1). Similarresults were also obtained with HNK (data
not shown). To test if theproteinreleased by epidermal cells
is biologically active, supernatants from FINK, A431, and
KB cellswere evaluated in the 1rM bioassay. These superna-
tants again demonstrated only minimal amounts of active
TNF-a until cells were treated with LPS (Fig. 2) .
To confirm that the cytotoxic activity against IrM cells
observed in HNK supernatants is due to TNF-a, WesternFigure 3 .
￿
Western blot analysis of keratinocyte-derivedTNF-a . Super-
natants derived from unstimulated (lane 5) or LPS (100 ug/ml)-treated
HNK (lane 4) were harvested after 24 hand run on a12%SDS gel . Staining
was performedwith amousemAb directed against recombinant human
TNF-a . As a positive control, recombinant human TNF-awas used at
different concentrations (100 ng, lane 1 ; 10 ng, lane 2; 1 ng, lane 3) .
blot analysis using a mAb directed against human TNF-ot
was performed. A weak, but clearly detectable band with
a molecular mass of 17 kD was observed in supernatants of
LPS-stimulated HNK (Fig . 3) .
To test whether the induction ofTNF-ci by epidermal cells
is regulated at the transcriptional level, the expression of
TNF-cimRNA in HNK and KB cells was examined . Un-
stimulatedKB cells expressed little TNF-cimRNA (Fig. 4,
lane 2), consistent with our previous biological data . How-
ever, treatment with LPS resulted in a marked increase in
the level of TNF-ci mRNA (Fig. 4, lane 1) .
SinceUVB light is wellknown to cause a significant dermal
inflammatory response in vivo and is a potent inducer of
cytokine production by epidermal cells in vitro as well (18),
HNK andKB cells were exposed toUVB irradiation . In com-
Figure4.
￿
KB cells expressmRNAencoding forTNFLa . KB cells were
stimulated with LPS (100Ag/ml, lane 1), left untreated (lane 2), or irradi-
ated with UVB (100 J/m2, lane 3) . After a 4-h incubation, RNA was
extracted and hybridized with a cDNA probe encoding for TNF-a .
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Figure 5.
￿
Stimulation ofTNF-a production byUVB irradiation. HNK
andKB cells were exposed to UVB light (100 J/m2) . After a 24-h incu-
bation, supernatants were tested forTNF-a using a TNF-a-specificBLISA.
Results are expressed as pg/ml t SD of three different experiments.
parison with supernatants of untreated cells, both irradiated
HNK and KB cells released significantly increased amounts
ofTNF-a (Fig . 5) . Maximum production was observed when
cells were exposed to 100J/m2, and supernatants were har-
vested after 24 h . In addition, UVexposedHNK and KB
expressed significantly increased TNF-amRNA as evaluated
by Northern blot analysis using a TNF-ot-specificcDNA probe
(Fig. 4, lane 3 ; Fig . 6) . Maximum TNF-ot expression was
detected whenRNA was extracted 12 h after UV treatment
(Fig. 6) .
After extensive solar exposure, increased levels ofcytokines
recently have been detected in the circulation (14, 18) . Thus,
serum samples from human healthy volunteers after total body
UV irradiation causing severe sunburn reaction were evalu-
Figure 6.
￿
Northern blot analysis ofUVtreated normal human keratino-
cytes . HNK cells were left untreated or irradiated with UVB light (100
J/m2), and total RNA was extracted at various time points and hybrid-
ized using 32P-labeled TNF-a-specific cDNA . The blot was stripped and
re-hybridized with a probe for fl-actin (bottom) confirming that theRNA
on the blot is intact, and that approximately equal amounts ofRNAwere
loaded in each lane.TMF alpha (PQ/ml)
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Figure 7.
￿
Serum TNF-a levels after UV treatment. Human healthy
volunteers (n - 4) were treated with a single total body UVB exposure
equivalent to four minimal erythema doses. Serum samples were obtained
before as well as 12 and 24 h after UV irradiation. TNF-a was evaluated
using the TNF-a-specific ELISA. Results are expressed as pg/ml mean
± SD.
ated for TNF-a using the TNF-a-specific ELISA. Serum
samples obtained before UVB exposure contained minimal
levels of TNF-a. However, significant circulating TNF-a was
detected 12 and 24 h after UVB treatment (Fig. 7).
Discussion
The present study demonstrates that both HNK and the
epidermoid carcinoma cell lines KB and A431 upon stimula-
tion release immunoreactive TNF-a. This cytokine is pro-
duced as a biologically inactive prohormone that has to be
cleaved at several sites to become the mature biologically ac-
tive polypeptide (19, 20). Therefore, in addition to the ELISA,
a TNF-a bioassay (IrM test) was utilized to prove that ker-
atinocytes release a biologically active TNF-a. Accordingly,
human keratinocytes produced low amounts of biologically
active TNF-a. Nevertheless, it is hard to compare quantities
of TNF-a measured with the ELISA with the quantity esti-
mated in the bioassay, since one has to be aware of the fact
that crudesupernatants of keratinocytes and epidermoid car-
cinoma cell linesusually contain several other mediators that
may interfere with bioassays (11). The identity of epidermal
cell-derived TNF-a protein was confirmed by Western blot
analysis usinga specific mAb directed against TNF-a, which
demonstrated a specific band with a molecular mass of 17 M
Keratinocytes constitutively secrete little TNF-a since
TNF-a protein was hardly detectable in supernatants of un-
treated epidermal cells. However, upon stimulation with LPS
or UVB, both FINK and epidermal carcinoma cellsproduced
significant amounts of TNF-a . The results were also con-
firmed by Northern blot analysis detecting TNF-oc mRNA
in keratinocytes after stimulation with LPS or UVB. The
present data clearly demonstrate that human keratinocytes
upon stimulation can function as a source of TNF-a. The
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quantities released, however, even after optimal induction,
are much less than the amounts produced by macrophages.
Human keratinocytes have been demonstrated to release
various cytokines, including IIrlaandjS (21), Ilr6 (22), Ilr8
(23), CSF, transforming growth factors (11), and platelet-
derived growth factor (10). Through the capacity to release
these mediators, keratinocytes may play an important role
in inflammatory reactions of the skin. Similar to the present
findings concerning keratinocyte TNF-a release, the consti-
tutive production of these factors both in vitro and in vivo
is very low and has tobe induced by various stimuli, including
bacterial or viral products, tumor promotors, UV light, or
cytokines themselves. TNF-a hasbeen demonstrated to stimu-
late the release of other mediators, such as I1J1, IIr6, IIr8,
granulocyte/macrophage (GM)-CSF, and platelet-derived
growth factor in various cell types (24-27), and thus appears
to be a key member of the cytokine cascade, playing an im-
portant role in pathologic events accompanying invasion of
foreign organisms. Since the epidermis is frequently in con-
tact with environmental microorganisms,it is not surprising
that epidermal cells appear to be endowed with the capacity
to release TNF-a. TNF-a functions in synergy with other
cytokines, exhibiting some antiviral activity (28), and thus
may be involved in the defense of the epidermis against viral
particles. Moveover, TNT-a, like ILl, increases ICAM-1 ex-
pression on fibroblasts, endothelial cells, and keratinocytes
(8), resulting in an enhanced adhesion oflymphocytes, which
may be important in certain lymphocyte-mediated skin dis-
eases. The role of TNF-a as a regulatory cytokine in im-
munological as well as inflammatory processes is further sup-
ported by the finding that TNF-a enhances T and B cell
functions, induces productionof other cytokines, and modu-
lates the activity of cytotoxic T cells (19).
An exaggerated release of TNF-a by the host can be toxic
to the host, which is best demonstrated by the crucial role
ofTNF-a in the pathogenesis ofendotoxic shockand cachexia
in sepsis (29). TNF-a may also be involved in mediating the
skin changes in GVHD. Accordingly, treatment of animals
with antiTNF antibodies prevents the development of cuta-
neous and intestinallesions during the acute phaseofGVHD
(30). Recently, TNF-a has been detected in humanepidermal
cells of skin biopsies obtained from healthy subjects, and
staining intensity was found increased after UVB exposure
(31). Due to the use ofonly immunohistochemical techniques,
this study did not definitely prove that keratinocytes are the
real source of TNF-a, since it cannot be exclu&d that the
cytokine is released by inflammatory cells in the dermis and
just bound on the surface of keratinocytes. The results of our
study, however, indicate that human keratinocytes appear to
be the most likely source for TNF-a found within the
epidermis.
According to the present data, UV light appears as an in-
ducer ofTNF-a productionby epidermal cells in vitro. Since
solar exposure can cause a significant inflammatory response
in the skin, TNF-a may be involved in the mediation of this
local reaction directly or via induction of other cytokines
(24-27). In addition, this study demonstrates that after ex-
tensive UV exposure, increased TNF-a levels can be detectedin the circulation and thus may be responsible for systemic
effects. Although keratinocytes are the primary target ofUVB
lightand a source for TNF-a, it cannotbe determinedwhether
TNF-a found in the circulation is keratinocyte derived or
not. Accordingly, cells other than keratinocytes (e.g., mac-
rophages) may be considered as the source for enhanced cir-
culating TNF-a, since in the present study, TNF-a serum
levels continue to increase out to 24 h, whereas in vitro the
message for TNF-a in keratinocytes has begun to decline at
that time. UV exposure suppresses the immune response
signficantly, e.g., blocks contact and delayed-type hypersen-
sitivity reaction in mice (32). Recently, it has been demon-
strated also that injection of TNF-a similar to exposure with
UVB light inhibits the induction of contact hypersensitivity,
suggesting that TNF-a released in enhanced amounts upon
UV irradiation may be involved in the suppression of the
immune response after UV exposure (33).
Currently, another remarkable function ofTNF-a within
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